The First Line of Defense: Primary Care Clinicians and Early Detection of Pancreatic Cancer Kenner Family Research Fund
-
- Health & Fitness
-
The First Line of Defense is a 4-part podcast specifically created for primary care clinicians on how they can recognize symptoms and risk factors of pancreatic cancer – including what the future holds for diagnosing patients using ever-developing technology, including AI. Kenner Family Research Fund and Entertainment 2 Affect Change have partnered to share the stories of pancreatic cancer patients, primary care physicians, leading researchers, and specialists in the field.
The goal of this podcast is to educate an informed, but not expert, medical audience on the current state of pancreatic cancer diagnostics, and provide usable tools for clinicians to walk away better equipped to detect a potential pancreatic cancer diagnosis. We want to raise awareness and provide tools for clinicians.
For More Information and Resources:
Visit our website at pancreaticcancerpodcast.com
Meet the People Behind the Microphone:
Jon Hallberg, MD | Sapna Syngal, MD, MPH | Suresh Chari, MD
William Hoos, MBA | Chris Sander, PHD | Steve & Scott Nelson
Learn More About KFRF:
Visit our website at kennerfamilyresearchfund.org
Follow E2AC:
Facebook | Instagram | Twitter | TikTok | LinkedIn
-
From Knowledge to Action: Early Detection of Pancreatic Cancer in Primary Care
In the first episode of the The First Line of Defense podcast, we discuss early detection of pancreatic cancer in primary care. While the initial presentation of pancreatic cancer can be vague and non-specific, if you’re suspicious, Primary Care Clinicians should consider imaging, such as an abdominal and pelvic CT scan for further evaluation.
-
Genetic Insights: Understanding Pancreatic Cancer Risk in Primary Care
In the second episode of the The First Line of Defense podcast, we discuss genetic insights and understanding pancreatic cancer risk in primary care. While there are many considerations a Primary Care Clinician has to make when diagnosing pancreatic cancer, family histories are an important piece of this complex puzzle.
-
From Data to Diagnosis: Transforming Early Detection of Pancreatic Cancer
Primary Care Clinicians have an important role to play, and it’s not easy. There is hope for the future of early detection with biomarkers and A-I. Not only is early detection increasingly more feasible, it makes a significant difference in survival.
-
A Conversation with Chris Sander on AI and the Prediction of Pancreatic Cancer
In this special bonus episode of The First Line of Defense podcast, Chris Sander, a computational biologist based at the Dana-Farber Cancer Center and Harvard Medical School, explains how his research on A-I and machine learning are being used to help with early cancer detection. Even with the multiple challenges inherent in AI, this study represents a much needed and valuable step in earlier cancer detection efforts.
Customer Reviews
Great for PCP awareness!
As an APRN who has a family member with BCCA2, I am always looking for the newest info regarding early detection for Pancreatic Ca. Great 4 Part podcast that helps me counsel my family and my patients.